Combined therapy with RAD001 e BEZ235 overcomes resistance of PET immortalized cell lines to mTOR inhibition

Pancreatic endocrine tumors (PETs) are characterised by an indolent behaviour in terms of tumor growth. However, most patients display metastasis at diagnosis and no cure is currently available. Since the PI3K/AKT/mTOR axis is deregulated in PETs, the mTOR inhibitor RAD001 represents the first line...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Passacantilli, Ilaria, Capurso, Gabriele, Archibugi, Livia, Calabretta, Sara, Caldarola, Sara, Loreni, Fabrizio, Fave, Gianfranco Delle, Sette, Claudio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Impact Journals LLC 2014
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4170632/
https://ncbi.nlm.nih.gov/pubmed/25026292
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items